Hospital News and Research

RSS

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

NovaBay Pharmaceuticals, Inc. today announced that its Aganocide® compounds demonstrate potent antifungal activity in an established pre-clinical infected nail model of onychomycosis. The study data will be presented tomorrow at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia.

31 Oct 2009

New teleneurology medicine program to provide 24-hour emergency services launched

Rural and small, suburban hospitals in North Carolina and Virginia can now provide a higher level of emergency stroke and critical neurology care, 24 hours a day, 365 days a year, as part of a new teleneurology medicine program announced Oct. 26, 2009, by Forsyth Medical Center (FMC).

31 Oct 2009

Vigilanz, Orlando Health and Contra Costa Regional Medical Center sign license agreement

VigiLanz Corporation has entered into contracts with Orlando Health, Inc., a group of seven hospitals in Orlando, Florida; and Contra Costa Regional Medical Center in Martinez, California, to license the VigiLanz product suite, consisting of the Dynamic PharmacoVigilance® (DPV) system, the Dynamic PracticeGuidance™ (DPG) system, and the VigiLanz Infection Control Monitor™ (ICM).

31 Oct 2009

NCI awards $4.8M for project to measure all the proteins in the human body

An expert in cancer proteomics at Fred Hutchinson Cancer Research Center has received $4.8 million in federal stimulus funding from the National Cancer Institute to co-lead a pilot study to assess the feasibility and scalability of a project that aims to measure all of the proteins in the human body.

31 Oct 2009

FDA-approved drug PEG-ADA shows positive results in relieving major complication of priapism

Thousands of men are afflicted with an embarrassing and painful condition that triggers spontaneous, long-lasting erections. There are limited treatment options, but a solution could be on the way thanks to new research at The University of Texas Health Science Center at Houston.

31 Oct 2009

Aetna signs new expanded agreement with Sarasota Memorial Hospital

Aetna announced today that it has expanded its relationship with Sarasota Memorial Hospital by reaching agreement on a long-term contract that will provide access for Aetna’s Medicare Advantage members. This agreement marks the first time Sarasota Memorial has agreed to participate in a Medicare Advantage network plan.

31 Oct 2009

Public concern can undermine flu vaccination campaigns

The effectiveness of pandemic flu vaccination campaigns - like that now underway for H1N1 - could be undermined by the public incorrectly associating coincidental and unrelated health events with the vaccines.

31 Oct 2009

Study: Lack of insurance may have caused 17,000 child deaths over 20 years

"An estimated 17,000 children in the United States might have died unnecessarily over nearly two decades because they didn't have health insurance, according to a report from researchers at Johns Hopkins Children's Center in Baltimore," reports U.S. News and World Report.

30 Oct 2009

Hyperthermia therapy delivered through BSD Medical's system improves survival rate for bladder cancer patients

BSD Medical Corporation today announced that published study results demonstrated improvement in overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy, delivered using the BSD-2000 Hyperthermia System, to the standard treatment regimen for 45 patients with high-risk bladder cancer.

30 Oct 2009

Aetna’s Medicare Advantage members to benefit from agreement with WellStar Health System

Aetna and WellStar Health System of Marietta, Ga. announced today that they have reached agreement on a three-year contract that provides access for Aetna’s Medicare Advantage members to the hospital’s facilities and physicians.

30 Oct 2009

Idenix Pharmaceuticals reports phase I study results of IDX184 for treating HCV

Idenix Pharmaceuticals, Inc.a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced presentations of data on IDX184, a once-daily novel liver-targeted nucleotide prodrug of 2'-methyl guanosine (2'MeG) for the treatment of HCV, at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) currently being held in Boston, Massachusetts.

30 Oct 2009

Left side grafting has lower risk to donors; small graft size not the only cause of 'small-for-size graft syndrome'

A recent study by doctors at Shinshu University, School of Medicine, in Japan determined that left side grafting has lower risk to donors compared to grafts taken from the right lobe, and it appears to be the procedure of choice for adult-to-adult living donor liver transplantation (LDLT).

30 Oct 2009

Michigan residents sue State over denied access to dental healthcare

In a move aimed at forcing the State of Michigan and the Legislature to protect the rights of Michigan's most vulnerable population, including the developmentally disabled and those with minimal financial resources, a lawsuit was filed in federal court against the Granholm Administration. A class of more than 400,000 at-risk Michigan residents is suing the State for failing to uphold its legal obligations with regard to funding certain dental care services under the federal Medicaid program.

30 Oct 2009

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

The Centers for Disease Control and Prevention (CDC) have classified all children, 6-months to 24-years, one of the high risk groups for contracting the H1N1 (swine) flu, and recommend this population receive the H1N1 vaccine for immunity against the disease.

30 Oct 2009

Participation in clinical trials may offer better prognosis for patients with chronic heart failure

Patients with chronic heart failure who agree to take part in clinical trials have a better prognosis than those who do not, according to a study reported in the November European Journal of Heart Failure.

30 Oct 2009

Identifying at risk dialysis units in the U.S. under the bundle payment system

The proposed Medicare "bundled" payment system for dialysis is likely to reduce government reimbursements for dialysis units in certain regions of the United States and for some types of facilities, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

30 Oct 2009

Celsius RMT ThermoCool catheter of Stereotaxis receives CE Mark for distribution in the European market

Stereotaxis received notice that the Celsius® RMT ThermoCool® catheter has received CE Mark for distribution in the European market. The product is the fifth advanced ablation catheter resulting from the on-going co-development agreement between Stereotaxis and Biosense Webster to design and distribute magnetically enabled catheters for use in the Niobe Magnetic Navigation System (MNS).

30 Oct 2009

AcelRx Pharmaceuticals completes End-of-Phase 2 meeting with the FDA for its ARX-01drug/device

AcelRx Pharmaceuticals, Inc. today announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company's proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route.

30 Oct 2009

The movie 'Precious' reflects the life of many others, says child abuse experts

The much-anticipated movie Precious opens on November 6. The film, whose executive producers include Oprah Winfrey, tells the bleak story of an obese, illiterate 16-year-old Harlem girl who is pregnant with her second child (the result both times of sexual assaults by her father) and who suffers daily verbal and physical abuse at the hands of her mother

30 Oct 2009

IGR Genomic Center awarded ISO 9001 certification

The Institut de cancérologie Gustave Roussy (IGR) France announced today that its Genomic Center has been awarded ISO 9001 certification for quality management and compliance to the highest standards of quality by Association Française de Normalisation (AFNOR), France’s national organization for standardization and certification.

30 Oct 2009

Hospital News and Research

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

New teleneurology medicine program to provide 24-hour emergency services launched

Vigilanz, Orlando Health and Contra Costa Regional Medical Center sign license agreement

NCI awards $4.8M for project to measure all the proteins in the human body

FDA-approved drug PEG-ADA shows positive results in relieving major complication of priapism

Aetna signs new expanded agreement with Sarasota Memorial Hospital

Public concern can undermine flu vaccination campaigns

Study: Lack of insurance may have caused 17,000 child deaths over 20 years

Hyperthermia therapy delivered through BSD Medical's system improves survival rate for bladder cancer patients

Aetna’s Medicare Advantage members to benefit from agreement with WellStar Health System

Idenix Pharmaceuticals reports phase I study results of IDX184 for treating HCV

Left side grafting has lower risk to donors; small graft size not the only cause of 'small-for-size graft syndrome'

Michigan residents sue State over denied access to dental healthcare

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

Participation in clinical trials may offer better prognosis for patients with chronic heart failure

Identifying at risk dialysis units in the U.S. under the bundle payment system

Celsius RMT ThermoCool catheter of Stereotaxis receives CE Mark for distribution in the European market

AcelRx Pharmaceuticals completes End-of-Phase 2 meeting with the FDA for its ARX-01drug/device

The movie 'Precious' reflects the life of many others, says child abuse experts

IGR Genomic Center awarded ISO 9001 certification

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News